Article
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations
10 Jan 2011
Abstract excerpt
Cancer cells are heterogeneous and, it has been proposed, fall into at least two classes: the tumor-initiating cancer stem cells (CSC) and the more differentiated tumor cells. The transmembrane protein CD133 has been widely used to isolate putative CSC populations in several cancer types, but its validity as a CSC marker and hence its clinical ramifications remain controversial. Here, we conducted transcriptomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.